NCT06168396

Brief Summary

This research is being done to test a new device, called the Somatosensation Device, with people who have either a below knee amputation, or neuropathy (i.e. decreased sensation) in their legs. When people have lost sensation in their feet, it may make walking and balance more difficult. The Somatosensation Device is designed to substitute the loss of feeling in a foot by pressing on nerves on the surface of the leg. It presses on the nerves by using a pneumatic balloon to put pressure on your skin. If people receive this extra sensation feedback, it may help improve their walking and balance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

November 22, 2023

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Gait Assessment (FGA)

    The Functional Gait Assessment is a test to assess an individual's postural stability and ability to perform multiple motor tasks while walking. Tests include walking at different speeds, walking with head turns, turns, stepping over obstacles, walking tandem, walking with eyes closed, walking backwards, and stair navigation. Scores are on a 0-30 scale, with higher scores showing better balance and mobility.

    Baseline, during the intervention

Secondary Outcomes (4)

  • 10 Meter Walk Test

    Baseline, during the intervention

  • Mini-BESTest

    Baseline, during the intervention

  • Activities Specific Balance Confidence Scale (ABC)

    Baseline, during the intervention

  • Vestibular Disorders Activities of Daily Living Scale (VADL)

    Baseline, during the intervention

Study Arms (2)

Baseline (Without Somatosensation Device)

ACTIVE COMPARATOR

Participants will perform all outcome measures without wearing the somatosensation device.

Other: Baseline

With Somatosensation Device

EXPERIMENTAL

Participants will perform all outcome measures while wearing the somatosensation device.

Device: Somatosensation Device

Interventions

The somatosensation device will be worn on the lower limb (either the residual limb for an amputee, or limb with decreased sensation for a participant with diabetic neuropathy) while performing outcome measures.

With Somatosensation Device

Participants will perform outcome measures without wearing the somatosensation device.

Baseline (Without Somatosensation Device)

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a below-knee amputation (either unilateral or bilateral) or neuropathy in their lower limbs.
  • Ability to wear the somatosensation device on their lower limbs
  • Ability to wear test equipment and heart rate monitors.
  • Ability to follow simple directions.

You may not qualify if:

  • History of severe back pain in the last 3 months.
  • History of severe knee pain in the last 3 months.
  • Unable to walk for 3 minutes with or without an assistive device
  • Poor skin integrity (i.e open wounds, skin breakdown) that could be made worse by wearing the somatosensation device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Interventions

BaseLine dental cement

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 22, 2023

First Posted

December 13, 2023

Study Start

March 1, 2024

Primary Completion

April 30, 2024

Study Completion

May 1, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Locations